Deutsch English Français

Contact

EP1370259

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1370259

EP1370259 - USE OF MELATONIN IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING ATTENTION DEFICIT HYPERACTIVE DISORDER [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 23.11.2007 Database last updated on 02.11.2024
Most recent event Tooltip	11.09.2009	Lapse of the patent in a contracting state New state(s): TR	published on 14.10.2009 [2009/42]
Applicant(s)	For all designated states Pooger Properties Limited P.O. Box 639, Sir Walter Raleigh House, 48/50 Esplanade St. Helier, Jersey, Channel Islands JE1 4HH / GB
	[2007/03]
Former [2003/51]	For all designated states Pooger Properties Limited P.O. Box 639, Sir Walter Raleigh House, 48/50 Esplanade, St. Helier Jersey, Channel Islands JE1 4HH / GB
Inventor(s)	01 / KRUISINGA, Roelof, Johannes, Hendrik Prins Frederiklaan 6 NL-2243 HW Wassenaar / NL
	[2003/51]
Representative(s)	Huygens, Arthur Victor Octrooibureau Huygens P.O. Box 86 3400 AB IJsselstein / NL
	[N/P]
Former [2003/51]	Huygens, Arthur Victor Octrooibureau Huygens, P.O. Box 86 3400 AB Ijsselstein / NL
Application number, filing date	02708364.1	22.03.2002
	[2003/51]
	WO2002EP03317
Priority number, date	EP20010201094	22.03.2001 Original published format: EP 01201094
	[2004/11]
Former [2003/51]	NL20011201094	22.03.2001
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO02076452
	Date:	03.10.2002
	Language:	EN
	[2002/40]
	Type:	A1 Application with search report
	No.:	EP1370259
	Date:	17.12.2003
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 03.10.2002 takes the place of the publication of the European patent application.
	[2003/51]
	Type:	B1 Patent specification
	No.:	EP1370259
	Date:	17.01.2007
	Language:	EN
	[2007/03]
Search report(s)	International search report - published on:	EP	03.10.2002
Classification	IPC:	A61K31/4045, A61P25/00	[2003/51]
	CPC:	A61K31/405 (EP,US); A61K31/4045 (EP,US); A61P25/00 (EP); A61P25/20 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/51]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	VERWENDUNG VON MELATONIN ZUR BEHANDLUNG DER MIT KONZENTRATIONSSCHWÄCHE EINHERGEHENDEN HYPERAKTIVITÄT	[2003/51]
	English:	USE OF MELATONIN IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING ATTENTION DEFICIT HYPERACTIVE DISORDER	[2003/51]
	French:	UTILISATION DE MELATONINE POUR LA PRODUCTION D'UN MEDICAMENT DESTINE A TRAITER UN TROUBLE DEFICITAIRE DE L'ATTENTION AVEC HYPERACTIVITE	[2003/51]
Entry into regional phase	08.10.2003	National basic fee paid
	08.10.2003	Designation fee(s) paid
	08.10.2003	Examination fee paid
Examination procedure	08.10.2003	Examination requested [2003/51]
	22.12.2003	Despatch of a communication from the examining division (Time limit: M09)
	05.11.2004	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	28.01.2005	Reply to a communication from the examining division
	11.11.2005	Communication of intention to grant the patent
	21.03.2006	Fee for grant paid
	21.03.2006	Fee for publishing/printing paid
	05.04.2006	Despatch of a communication from the examining division (Time limit: M06)
	14.10.2006	Reply to a communication from the examining division
Opposition(s)	18.10.2007	No opposition filed within time limit [2007/52]
Request for further processing for:	15.01.2005	Request for further processing filed
	15.01.2005	Full payment received (date of receipt of payment) Request granted
	15.02.2005	Decision despatched
Fees paid	Renewal fee
	30.03.2004	Renewal fee patent year 03
	30.03.2005	Renewal fee patent year 04
	29.09.2006	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	31.03.2006	05 M06 Fee paid on 29.09.2006
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	17.01.2007
	DK	17.01.2007
	FI	17.01.2007
	TR	17.01.2007
	LU	22.03.2007
	MC	31.03.2007
	SE	17.04.2007
	GR	18.04.2007
	PT	18.06.2007
	[2009/42]
Former [2009/38]	CY	17.01.2007
	DK	17.01.2007
	FI	17.01.2007
	LU	22.03.2007
	MC	31.03.2007
	SE	17.04.2007
	GR	18.04.2007
	PT	18.06.2007
Former [2009/33]	CY	17.01.2007
	DK	17.01.2007
	FI	17.01.2007
	MC	31.03.2007
	SE	17.04.2007
	GR	18.04.2007
	PT	18.06.2007
Former [2008/21]	DK	17.01.2007
	FI	17.01.2007
	MC	31.03.2007
	SE	17.04.2007
	GR	18.04.2007
	PT	18.06.2007
Former [2008/09]	DK	17.01.2007
	FI	17.01.2007
	MC	31.03.2007
	SE	17.04.2007
	PT	18.06.2007
Former [2007/46]	DK	17.01.2007
	FI	17.01.2007
	SE	17.04.2007
	PT	18.06.2007
Former [2007/38]	FI	17.01.2007
	SE	17.04.2007
	PT	18.06.2007
Cited in	International search	[A] - HOBAN T F, "SLEEPLESSNESS IN CHILDREN WITH NEURODEVELOPMENTAL DISORDERS EPIDEMIOLOGY AND MANAGEMENT", CNS DRUGS, ADIS INTERNATIONAL, AUCKLAND, NZ, (200007), vol. 14, no. 1, ISSN 1172-7047, pages 11 - 22, XP001013140 [A] 1-4,6 * page 20, column 1, paragraph 2 - column 2, paragraph 1; table III * DOI: http://dx.doi.org/10.2165/00023210-200014010-00002
		[A] - JADAD A R ET AL, "THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER: AN ANNOTATED BIBLIOGRAPHY AND CRITICAL APPRAISAL OF PUBLISHED SYSTEMATIC REVIEWS AND METAANALYSES", CANADIAN JOURNAL OF PSYCHIATRY. REVUE CANADIENNE DE PSYCHIATRIE, CANADIAN PSYCHIATRIC ASSOCIATION, OTTAWA, CA, (1999), vol. 44, no. 10, ISSN 0706-7437, pages 1025 - 1035, XP000884705 [A] 1-4,6 * table 3A *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p